Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Nov 16, 2020; 12(11): 408-450
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Ref. | Year | Country | Study design | n | Procedure | Medication | Relative risk |
Yamamiya et al[122] | 2019 | Japan | Retrospective | 76 | Sphincterotomy | DOAC either: (1) Continued; (2) Switched to HBT before | No incidence of PPB in either continuous or HBT group |
Muro et al[138] | 2020 | Japan | Retrospective | 62 (149) | Sphincterotomy | DOAC: (1) Continued; (2) With HBT | No incidence of PPB (continued DOAC). Incidence of PPB 6.5% (HBT) |
- Citation: Chan A, Philpott H, Lim AH, Au M, Tee D, Harding D, Chinnaratha MA, George B, Singh R. Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. World J Gastrointest Endosc 2020; 12(11): 408-450
- URL: https://www.wjgnet.com/1948-5190/full/v12/i11/408.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i11.408